MHRA delivers record performance as 2025 to 2026 Annual Report and Accounts confirms growing global influence

22nd July 2026

Summary: The Medicines and Healthcare products Regulatory Agency (MHRA) has published its 2025 to 2026 Annual Report and Accounts, highlighting a year of strong performance in protecting public health, supporting the UK's life sciences sector and driving innovation. Key achievements include approving 921 medicinal products, assessing 100% of clinical trial and national medicines licence applications within target timelines, removing a record 28.5 million doses of illegally traded medicines from circulation, advancing AI regulation, and securing World Health Organization Listed Authority status. The report also outlines priorities for 2026 to 2027, including implementing new Clinical Trials Regulations and launching the MHRA2030 Strategy.

Link: https://www.gov.uk/government/news/mhra-delivers-record-performance-as-2025-26-annual-report-and-accounts-confirms-growing-global-influence

Back to Recent News